Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Methylation of the BRCA1 promoter in peripheral blood DNA is associated with triple-negative and medullary breast cancer.
Association between methylation and breast cancer was restricted to women with no constitutional BRCA1 mutation.
»
08/25/14
miR-200c Inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3.
miR-200c appears to control the EMT process through BMI-1.
»
06/16/14
A high level of circulating HOTAIR is associated with progression and poor prognosis of cervical cancer.
High HOTAIR was notably correlated with tumor recurrence.
»
08/20/14
Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
Catalpol promoted apoptosis and caused the cell-cycle arrest at G2/M phase.
»
11/13/14
Efficacy of eribulin in women with metastatic breast cancer: a pooled analysis of two phase 3 studies.
Eribulin improves OS in various patient subgroups.
»
06/24/14
Association of SULT1A1 Arg(213)His polymorphism with male breast cancer risk: results from a multicenter study in Italy.
SULT1A1 Arg(213)His may act as a low-penetrance risk allele for developing MBC.
»
10/02/14
Common filaggrin gene mutations and risk of cervical cancer.
Carriage of FLG mutations was not associated with the risk of cervical cancer.
»
11/11/14
The cyclic AMP pathway is a sex-specific modifier of glioma risk in type 1 neurofibromatosis patients.
Sex-specific role for cAMP regulation in human gliomagenesis.
»
11/09/14
Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer.
SET overexpression is a frequent event in metastatic CRC.
»
11/13/14
B-Raf inhibitors induce epithelial differentiation in BRAF-mutant colorectal cancer cells.
PLX4720 also suppressed several metastasis-associated transcripts.
»
11/09/14
< Prev
Next >